arrow
S

Shoichi Fukui

Nagasaki University Graduate School of Biomedical Sciences
H指数:23
被引数:2,200

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical phenotypes of ANCA-associated vasculitis using ensemble clustering: prognostic and therapeutic insights from two Japanese cohorts

基于集成聚类的ANCA相关性血管炎临床表型:来自两个日本队列的预后和治疗见解

2026-09-170
OAAI
Divergent proviral load trajectories and clonal dynamics of HTLV-1-infected cells during antirheumatic therapy in rheumatoid arthritis

类风湿关节炎抗风湿治疗期间HTLV-1感染细胞的病毒载量轨迹分歧和克隆动态

2026-09-120
OA
Phenotype, serotype, and data-driven clustering reveal complementary dimensions of heterogeneity in ANCA-associated vasculitis: a multicentre Japanese cohort (J-CANVAS)

表型、血清型和数据驱动聚类揭示了ANCA相关性血管炎中异质性的互补维度:一项多中心日本队列(J-CANVAS)

2025-11-120
OAAI
Real-world effectiveness of rituximab or intravenous cyclophosphamide versus non-use in patients with severe microscopic polyangiitis and granulomatosis with polyangiitis: a retrospective cohort study of J-CANVAS

利妥昔单抗或静脉注射环磷酰胺与非用药在重症显微镜下多血管炎和肉芽肿性多血管炎患者中的真实世界有效性:一项J-CANVAS回顾性队列研究

2025-11-010
PRE
Diabetes mellitus and cardiac disease as key predictors of rituximab-induced acute thrombocytopenia in ANCA-associated vasculitis

糖尿病和心脏疾病作为利妥昔单抗诱导的ANCA相关性血管炎急性血小板减少症的关键预测因子

2025-10-010
PRE
Myeloperoxidase-anti-neutrophil cytoplasmic antibody positivity and disease characteristics, treatment, and prognosis in eosinophilic granulomatosis with polyangiitis
2025-10-010
PRE
Treatment outcomes stratified by interferon profile and autoantibodies in rheumatoid arthritis

类风湿关节炎中按干扰素谱和自身抗体分层的治疗效果

2025-09-300
PRE
Exploring the Clinical Diversity of Castleman Disease and TAFRO Syndrome: A Japanese Multicenter Study on Lymph Node Distribution Patterns

探索Castleman Disease和TAFRO Syndrome的临床多样性:一项关于淋巴结分布模式的日本多中心研究

2025-01-251
OAAI